News About: Pharm. Industry


Will Pfizer become a new power in health functional food market with new ‘Centrum’?

Pfizer will release 6 new types of ‘Centrum’ to successfully settle in the health function food market. The consumer healthcare department of Pfizer Pharmaceuticals Korea(CEO/President Dong-Wook Oh) held a press conf...

Japanese pharmas stingy in donating money as social contributions

Although Japanese pharmaceutical companies branching in Korea are growing up with product quality and marketing power, they are criticized to neglect social contributions of corporate profit, which are a fundamental d...

Japanese pharmas earn 77 out of selling KRW 1,000

Japanese pharmaceutical companies were observed to generate KRW 77 profits by selling products(including goods and merchandises) worth of KRW 1,000 in the Korean market. Yakup Shinmoon(www.yakup.com) analyzed 2016 au...

Rapid adoption of AI in developing new drugs ahead of Fourth Industrial Revolution

Ahead of the Fourth Industrial Revolution, Korean and foreign pharmaceutical companies are quickly moving forward to utilize artificial intelligence(AI) into developing new drugs. The trend has been highlighted in maj...

Hanmi Pharm registers ‘Esomezol’

‘Esomezol,’ an acid reflux treatment developed by Hanmi Pharm, was registered at the U.S. Pharmacopeial(USP) for the first time as a Korean pharmaceutical company. Esomezol is the Korea’s first incrementally modified ...

Japanese pharmas’ rapid growth in Korean pharmaceutical market

Japanese multinational pharmaceutical companies branching in Korea were analyzed to record excellent sales performances last year. Yakup Shinmoon(www.yakup.com) analyzed 2016 audit reports turned in by Korean branche...

Employees at Korean branches of Japanese pharma earn KRW 74 million per employee a year

It was observed employees working at a Korean branch of multinational Japanese pharmaceutical company earns KRW 74 million per employee a year on average, and annual wages of an employee at Takeda Pharmaceuticals Kore...

“We’ll exclude unethical companies in certifying innovative pharmaceutical company”

The Ministry of Health and Welfare(MOHW) will tighten social responsibilities and ethical standards on innovative pharmaceutical companies. In response to a recent criticism “It is irrational to provide preferential ...

“It is not allowed to provide indirect rebates using support for foreign symposiums”

The pharmaceutical industry stressed importance of following the fair trade agreement and law by introducing examples of indirect provision of rebates using support for doctors on foreign symposium. It basically mean...

Sanofi eliminates a series of existing client distribution companies in Boehringer’s OTC business

It was told as Sanofi acquires the Boehringer Ingelheim’s OTC business, Sanofi stopped having businesses with a number of its existing client pharmaceutical distribution. Because the distribution companies whose busi...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.